A first-in-human study of MIL95, an anti-CD47 monoclonal antibody (mAb), in patients with advanced solid tumors and lymphomas

被引：0
|
作者：
Zhang, Qingyuan
Liu, Aiguo
Shi, Jianhua
Cai, Qingqing
Qu, Zerui
Liu, Sijun
Song, Yuqin
机构：
[1] Harbin Med Univ Canc Hosp, Harbin, Peoples R China
[2] Anhui Jimin Canc Hosp, Hefei, Peoples R China
[3] Linyi Canc Hosp, Dept Med Oncol, Linyi, Shandong, Peoples R China
[4] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Peoples R China
[5] Beijing Mabworks Biotech Co Ltd, Beijing, Peoples R China
[6] Peking Univ Canc Hosp & Inst, Dept Lymphoma, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14513
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase Ia first-in-human study of JS']JS007, a novel anti-CTLA-4 monoclonal antibody, in patients with advanced solid tumors
    Zhang, J.
    Zhou, C.
    Jiang, J.
    Liu, H.
    Xiang, X.
    Wu, G.
    Zeng, R.
    Kuang, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S633 - S633
  • [32] First-in-human study of AMG 820, a monoclonal anti-CSF-1R (c-fms) antibody, in patients (pts) with advanced solid tumors
    Papadopoulos, Kyriakos
    Gluck, Larry
    Martin, Lainie P.
    Olszanski, Anthony J.
    Ngarmchamnanrith, Gateree
    Rasmussen, Erik
    Amore, Benny
    Nagorsen, Dirk
    Hill, John S.
    Stephenson, Joe
    CANCER RESEARCH, 2016, 76
  • [33] A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas
    Hong, David S.
    Kurzrock, Razelle
    Supko, Jeffrey G.
    He, Xiaoying
    Naing, Aung
    Wheler, Jennifer
    Lawrence, Donald
    Eder, Joseph Paul
    Meyer, Colin J.
    Ferguson, Deborah A.
    Mier, James
    Konopleva, Marina
    Konoplev, Sergej
    Andreeff, Michael
    Kufe, Donald
    Lazarus, Hillard
    Shapiro, Geoffrey I.
    Dezube, Bruce J.
    CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3396 - 3406
  • [34] Guidance for transfusion management in patients receiving magrolimab therapy (anti-CD47 monoclonal antibody)
    Tan, Michelle
    Zacher, Nicole
    French, Rae
    Borosak, Marija
    Lennard, Samantha
    Le Viellez, Annette
    Benson, Simon
    Daly, James
    INTERNAL MEDICINE JOURNAL, 2022, 52 (12) : 2165 - 2171
  • [35] A first-in-human phase I study of ATG-031, anti-CD24 antibody, in patients with advanced solid tumors or B-cell non-Hodgkin lymphomas (PERFORM).
    Fu, Siqing
    Piha-Paul, Sarina A.
    Singh, Shivani
    Peng, Jing
    Keenan, Bridget P.
    Mei, Jay M.
    Lynch, Kevin
    Li, Ling
    Song, Ming
    Zhang, Xiaojing
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [36] A first-in-human, phase I, dose-escalation study to evaluate pharmacokinetics, safety, and tolerability of KD6001, a novel anti-CTLA-4 monoclonal antibody (mAb) in patients with advanced solid tumors
    Tang, Bixia
    Duan, Rong
    Li, Siming
    Sheng, Xinan
    Si, Lu
    Cui, Chuanliang
    Mao, Lili
    Wang, Xuan
    Lian, Bin
    Wei, Xiaoting
    Yan, Xieqiao
    Li, Juan
    Zhou, Li
    Xu, Huayan
    Li, Caili
    Cai, Zeling
    Zhang, Chi
    Wang, Fangfang
    Guo, Jun
    Chi, Zhihong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] A first-in-human phase I study of the anti-PD-1 antibody PDR001 in patients with advanced solid tumors
    Naing, Aung
    Gelderblom, Hans
    Gainor, Justin F.
    Forde, Patrick M.
    Butler, Marcus
    Lin, Chia-Chi
    Sharma, Sunil
    de Olza, Maria Ochoa
    Schellens, Jan H. M.
    Soria, Jean-Charles
    Taylor, Matthew H.
    Silva, Antonio P.
    Li, Zhonggai
    Bilic, Sanela
    Cameron, Scott
    Infante, Jeffrey R.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid Tumors
    Eng, Cathy
    Lakhani, Nehal J.
    Philip, Philip A.
    Schneider, Charles
    Johnson, Benny
    Kardosh, Adel
    Chao, Mark P.
    Patnaik, Amita
    Shihadeh, Fadi
    Lee, Yeonju
    Song, Kai
    Jin, Denise
    Huo, Yanan
    Howland, Michael
    Fisher, George A.
    Hecht, J. Randolph
    TARGETED ONCOLOGY, 2025,
  • [39] First-in-human, phase I study of AK109, an anti-VEGFR2 antibody in patients with advanced or metastatic solid tumors
    Zheng, Y.
    Zhong, H.
    Zhao, F.
    Zhou, H.
    Mao, C.
    Lv, W.
    Yuan, M.
    Qian, J.
    Jiang, H.
    Wang, Z.
    Xiao, C.
    Guo, J.
    Liu, T.
    Liu, W.
    Wang, Z. M.
    Li, B.
    Xia, M.
    Xu, N.
    ESMO OPEN, 2023, 8 (02)
  • [40] Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors
    Patnaik, Amita
    Weiss, Glen J.
    Leonard, John E.
    Rasco, Drew Warren
    Sachdev, Jasgit C.
    Fisher, Terrence L.
    Winter, Laurie A.
    Reilly, Christine
    Parker, Robert B.
    Mutz, Danielle
    Blaydorn, Lisa
    Tolcher, Anthony W.
    Zauderer, Maurice
    Ramanathan, Ramesh K.
    CLINICAL CANCER RESEARCH, 2016, 22 (04) : 827 - 836
12345